Category: Latest News
-
Edible Garden Secures Multi-Year Private Label Supply Agreement Through 2028
Edible Garden (NASDAQ:EDBL) has expanded its partnership with a major Midwest big-box retailer through a new multi-year private label supply agreement that extends through the end of 2028, strengthening its retail footprint and supporting its controlled environment agriculture growth strategy. Key Investor Takeaways Why EDBL Stock Is in Focus Edible Garden announced an expanded multi-year…
-
Reliance Global Group Signs LOI to Sell Altruis Subsidiary for $11 Million in Cash
Reliance Global Group (NASDAQ:EZRA) has signed a non-binding letter of intent to sell its Altruis Benefit Consulting subsidiary for $11 million in cash, a transaction that could eliminate the company’s term debt while providing additional capital to invest in its AI platform and InsurTech initiatives. Key Investor Takeaways Why EZRA Stock Is in Focus Reliance…
-
Hydrofarm Completes Aurora Peat Sale and Launches Project Agility to Strengthen Strategic Focus
Hydrofarm Holdings Group (NASDAQ:HYFM) has completed the $16 million sale of Aurora Peat Products and introduced Project Agility, a new initiative aimed at expanding its logistics services platform while simplifying operations and reducing debt. Key Investor Takeaways Why HYFM Stock Is in Focus Hydrofarm announced the completion of the divestiture of Aurora Peat Products to…
-
KIDZ AI Signs Data Center MOU to Advance $44.6 Million Canopy Wave GPU Compute Agreement
KIDZ AI (NASDAQ:KIDZ) has signed a non-binding memorandum of understanding with Limestone Networks to evaluate the deployment of AI inference infrastructure at a Dallas data center, marking the next operational step toward supporting its previously announced $44.6 million GPU compute services agreement with Canopy Wave. Key Investor Takeaways Why KIDZ AI Stock Is in Focus…
-
Tyson Foods Misses Third-Quarter Expectations and Cuts Full-Year Outlook
Tyson Foods Inc. (NYSE:TSN) reported third-quarter fiscal 2026 results on Monday that fell short of Wall Street forecasts, while lowering its full-year earnings outlook as ongoing challenges in its beef business continued to weigh on performance. The weaker-than-expected results sent the company’s shares down 3.50% in pre-market trading. Earnings and Revenue Fall Short of Forecasts…
-
Lindblad Expeditions Tops Second-Quarter Estimates as Revenue Climbs 19%
Lindblad Expeditions Holdings, Inc. (NASDAQ:LIND) reported second-quarter 2026 results on Monday that exceeded Wall Street expectations, as higher occupancy levels and stronger pricing helped drive double-digit revenue growth. The stronger-than-expected performance sent the expedition cruise operator’s shares up 4.53% in pre-market trading. Earnings and Revenue Beat Forecasts The company posted a quarterly loss of $0.02…
-
Hess Midstream Beats Second-Quarter Estimates and Reaffirms 2026 Outlook
Hess Midstream LP (NYSE:HESM) reported second-quarter 2026 results on Monday that came in ahead of Wall Street expectations, while reaffirming its full-year financial guidance despite lower throughput volumes across much of its business. The stronger-than-expected earnings helped lift the company’s shares 2.87% in pre-market trading. Earnings and Revenue Top Forecasts Adjusted earnings per share came…
-
Wall Street Set for Higher Open as Oil Prices Tumble on Iran Diplomacy Hopes: Dow Jones, S&P, Nasdaq, Futures
U.S. stock index futures pointed to a stronger open on Monday, with investors expected to build on last week’s gains as a sharp decline in crude oil prices improved overall market sentiment. The drop in oil followed renewed optimism over diplomatic efforts in the Middle East after U.S. President Donald Trump announced he had called…
-
Indivior Shares Surge After Strong Quarterly Results and Higher 2026 Outlook
Indivior Pharmaceuticals Inc. (NASDAQ:INDV) reported better-than-expected second-quarter 2026 results on Monday, driven by record sales of its opioid use disorder treatment SUBLOCADE, while raising its full-year financial guidance. The stronger outlook sent the pharmaceutical company’s shares up 9.22% in pre-market trading. Earnings and Revenue Top Expectations Indivior posted adjusted earnings of $1.15 per share for…
-
Genprex Shares Rise After Collaboration With Roche Diagnostics
Genprex Inc. (NASDAQ:GNPX) shares gained 3% on Monday after the clinical-stage biotechnology company announced a collaboration with Roche Diagnostics to validate biomarkers designed to improve patient selection in clinical trials for non-small cell lung cancer (NSCLC). Partnership Focuses on Biomarker Validation The collaboration will focus on validating the use of TROP2 as a biomarker to…